EGFR-IN-38 - CAS 2711105-50-7

EGFR-IN-38 is a low-toxicity, acrylamide derivative antitumor agent that is a potent inhibitor of EGFR. Among others, overexpression and mutation of the epidermal growth factor receptor (EGFR) has been shown to lead to uncontrolled cell growth and is associated with the progression of most cancer diseases, especially NSCLC. EGFR-IN-38 exhibits potential for research in EGFR mutation-related diseases.

Others, EGFR

JAK/STAT signaling, Others, Tyrosine Kinase/Adaptors, Angiogenesis

2711048

C25H24ClN7O2

489.96

NC1=C2N(N=C(C2=NC=N1)C3CN(C(C=C)=O)CCC3)C4=CC(Cl)=C(OCC5=CC=CC=N5)C=C4

-20°C

Ice Packs

Small Compound